Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment.

Area of Science:

• Biomedical Engineering
• Drug Discovery
• Cell Biology

Background:

• Traditional 2D cell cultures do not fully replicate in vivo conditions, limiting drug screening accuracy.
• 3D cell models, like tumor spheroids, offer better biomimicry but face challenges in high throughput screening.
• Current spheroid-based screening is time-consuming, reagent-intensive, and prone to cell loss.

Purpose of the Study:

• To develop an accessible micro-scaffold array chip for high throughput 3D cell culture and drug screening.
• To overcome limitations of current 3D cell culture methods in drug discovery.
• To enable quantitative in situ assays on a single, integrated platform.

Main Methods:

• Designed and utilized an off-the-shelf micro-scaffold array chip with sponge-like structures.
• Implemented parallel auto-loading of cells and drugs into isolated micro-scaffolds.
• Employed centrifugation for medium exchange, preventing cell loss and reducing consumption.
• Demonstrated drug cytotoxicity testing on cancer cells using standard laboratory equipment.

Main Results:

• Achieved rapid manual loading of cells/drugs into 96 micro-scaffolds within seconds.
• Reduced total medium consumption to microliters.
• Observed higher cellular drug resistance in 3D micro-scaffold cultures compared to 2D.
• Found 3D drug resistance to be density-independent, unlike density-dependent 2D responses.

Conclusions:

• The micro-scaffold array chip facilitates high throughput 3D cell culture and drug screening.
• This platform enhances the biomimicry of in vitro drug testing, improving accuracy.
• It offers a accessible and efficient solution for advancing drug discovery and cancer research.